# Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

> **NCT06603402** · PHASE2 · RECRUITING · sponsor: **Sichuan University** · enrollment: 41 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma (ESCC)
- Immunotherapy

## Interventions

- **RADIATION:** low-dose involved-field radiotherapy combined with immunochemotherapy

## Key facts

- **NCT ID:** NCT06603402
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-24
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06603402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06603402, "Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06603402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*